Pipeline Progress at Prothena Zacks.com Moreover, Roche and Prothena will initiate a research collaboration focusing on optimizing early stage antibodies targeting alpha-synuclein. This research collaboration will include incorporation of Roche's proprietary Brain Shuttle(TM) technology to ... Why Prothena Corporation PLC Shares Leaped Higher First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson's ... |
